KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals

Author's Avatar
Nov 08, 2022

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions, today announced the progression of its agreement with Kira Pharmaceuticals, including expansion into three important additional indications.